Literature DB >> 28685219

Clinicopathological Significance of Micropapillary Pattern in Lung Adenocarcinoma.

Jung-Soo Pyo1, Joo Heon Kim2.   

Abstract

The aim of this study was to elucidate the clinicopathological characteristics of the micropapillary (MP) subtype and its correlation with survival in lung adenocarcinoma. We investigated the clinicopathological characteristics, including the incidence, sex, smoking history, tumor size, lymph node metastasis, lymphovascular invasion, distant metastasis, genetic alteration, and prognosis in lung adenocarcinoma with the MP pattern through a meta-analysis. From 48 eligible studies, 19,502 lung adenocarcinomas were included. The incidence rate of the MP pattern was 0.101 [95% confidence interval (CI) 0.075-0.136]. There was no significant difference between stage I and III tumors. Lung adenocarcinoma with the MP pattern showed higher rates of lymphatic invasion (0.526, 95% CI 0.403-0.645). MP pattern was found in 0.150 (95% CI 0.008-0.790) of lung adenocarcinoma with distant metastasis. In lung adenocarcinoma with the MP pattern, the estimated rates of ALK, EGFR, and KRAS mutations were 0.102 (95% CI 0.027-0.322), 0.620 (95% CI 0.444-0.769), and 0.118 (95% CI 0.027-0.393), respectively. The MP pattern of lung adenocarcinoma was significantly correlated with worse overall and disease-free survival rates (hazard ratio 1.704, 95% CI 1.216-2.387, and 2.082, 95% CI 1.541-2.813, respectively). Taken together, identification of the MP pattern in lung adenocarcinoma is useful for prediction of clinicopathological characteristics and prognosis of patients.

Entities:  

Keywords:  Clinicopathological characteristics; Lung adenocarcinoma; Meta-analysis; Micropapillary pattern

Mesh:

Year:  2017        PMID: 28685219     DOI: 10.1007/s12253-017-0274-7

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  59 in total

1.  Clinical impact of minimal micropapillary pattern in invasive lung adenocarcinoma: prognostic significance and survival outcomes.

Authors:  Geewon Lee; Ho Yun Lee; Ji Yun Jeong; Joungho Han; Min Jae Cha; Kyung Soo Lee; Jhingook Kim; Young Mog Shim
Journal:  Am J Surg Pathol       Date:  2015-05       Impact factor: 6.394

2.  Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (</=20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours).

Authors:  Y Makimoto; K Nabeshima; H Iwasaki; T Miyoshi; S Enatsu; T Shiraishi; A Iwasaki; T Shirakusa; M Kikuchi
Journal:  Histopathology       Date:  2005-06       Impact factor: 5.087

3.  Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.

Authors:  Hang Li; Yunjian Pan; Yuan Li; Chenguang Li; Rui Wang; Haichuan Hu; Yang Zhang; Ting Ye; Lei Wang; Lei Shen; Yihua Sun; Haiquan Chen
Journal:  Lung Cancer       Date:  2012-10-23       Impact factor: 5.705

4.  Lepidic and micropapillary growth pattern and expression of Napsin A can stratify patients of stage I lung adenocarcinoma into different prognostic subgroup.

Authors:  Xin Yang; Yu Liu; Fang Lian; Lei Guo; Peng Wen; Xiu-Yun Liu; Dong-Mei Lin
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

5.  Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma.

Authors:  Tomoharu Yoshiya; Takahiro Mimae; Yasuhiro Tsutani; Norifumi Tsubokawa; Shinsuke Sasada; Yoshihiro Miyata; Kei Kushitani; Yukio Takeshima; Shuji Murakami; Hiroyuki Ito; Haruhiko Nakayama; Morihito Okada
Journal:  Ann Thorac Surg       Date:  2016-06-23       Impact factor: 4.330

6.  Correlation between morphology and EGFR mutations in lung adenocarcinomas Significance of the micropapillary pattern and the hobnail cell type.

Authors:  Hironori Ninomiya; Miyako Hiramatsu; Kentaro Inamura; Kimie Nomura; Michiyo Okui; Tatsu Miyoshi; Sakae Okumura; Yukitoshi Satoh; Ken Nakagawa; Makoto Nishio; Takeshi Horai; Satoshi Miyata; Eiju Tsuchiya; Masashi Fukayama; Yuichi Ishikawa
Journal:  Lung Cancer       Date:  2008-06-20       Impact factor: 5.705

7.  EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype.

Authors:  Arne Warth; Roland Penzel; Heike Lindenmaier; Regine Brandt; Albrecht Stenzinger; Esther Herpel; Benjamin Goeppert; Michael Thomas; Felix J F Herth; Hendrik Dienemann; Philipp A Schnabel; Peter Schirmacher; Hans Hoffmann; Thomas Muley; Wilko Weichert
Journal:  Eur Respir J       Date:  2013-08-29       Impact factor: 16.671

8.  Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.

Authors:  Jizhuang Luo; Qingyuan Huang; Rui Wang; Baohui Han; Jie Zhang; Heng Zhao; Wentao Fang; Qingquan Luo; Jun Yang; Yunhai Yang; Lei Zhu; Tianxiang Chen; Xinghua Cheng; Yiyang Wang; Jiajie Zheng; Han Wu; Weicong Xia; Haiquan Chen
Journal:  J Cancer Res Clin Oncol       Date:  2016-07-05       Impact factor: 4.553

9.  Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.

Authors:  Noriko Motoi; Janos Szoke; Gregory J Riely; Venkatraman E Seshan; Mark G Kris; Valerie W Rusch; William L Gerald; William D Travis
Journal:  Am J Surg Pathol       Date:  2008-06       Impact factor: 6.394

10.  Lymphatic invasion of micropapillary cancer cells is associated with a poor prognosis of pathological stage IA lung adenocarcinomas.

Authors:  Hiroshi Hirano; Hajime Maeda; Yukiyasu Takeuchi; Yoshiyuki Susaki; Ryozi Kobayashi; Akio Hayashi; Naoko Ose; Toshihiko Yamaguchi; Soichiro Yokota; Masahide Mori
Journal:  Oncol Lett       Date:  2014-06-25       Impact factor: 2.967

View more
  8 in total

1.  Not like breast cancer, but like breast cancer: micrometastasis and micropapillary structure in lung cancer.

Authors:  Katsuhiro Masago; Shiro Fujita; Yasushi Yatabe
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

2.  Papillary Renal Cell Carcinomas Demonstrating Micropapillary Features: An Investigation Into the Diagnostic and Prognostic Implications.

Authors:  Beatriz Caraballo; Maha Abdulla; Sunder Sham; Guang-Qian Xiao; Pamela Unger
Journal:  Cureus       Date:  2022-05-12

3.  How long is cessation of preoperative smoking required to improve postoperative survival of patients with pathological stage I non-small cell lung cancer?

Authors:  Toshiyuki Shima; Tomonari Kinoshita; Mao Uematsu; Naomichi Sasaki; Yusuke Sugita; Reiko Shimizu; Masahiko Harada; Tsunekazu Hishima; Hirotoshi Horio
Journal:  Transl Lung Cancer Res       Date:  2020-10

4.  Predictive value of radiological features on spread through air space in stage cIA lung adenocarcinoma.

Authors:  Zhenrong Zhang; Zhan Liu; Hongxiang Feng; Fei Xiao; Weipeng Shao; Chaoyang Liang; Hongliang Sun; Xinlei Gu; Deruo Liu
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

5.  Consolidation Tumor Ratio Combined With Pathological Features Could Predict Status of Lymph Nodes of Early-Stage Lung Adenocarcinoma.

Authors:  Liang Zhao; Guangyu Bai; Ying Ji; Yue Peng; Ruochuan Zang; Shugeng Gao
Journal:  Front Oncol       Date:  2022-01-14       Impact factor: 6.244

6.  Expansion of the Concept of Micropapillary Adenocarcinoma to Include a Newly Recognized Filigree Pattern as Well as the Classical Pattern Based on 1468 Stage I Lung Adenocarcinomas.

Authors:  Katsura Emoto; Takashi Eguchi; Kay See Tan; Yusuke Takahashi; Rania G Aly; Natasha Rekhtman; William D Travis; Prasad S Adusumilli
Journal:  J Thorac Oncol       Date:  2019-07-25       Impact factor: 15.609

7.  A comprehensive study on the oncogenic mutation and molecular pathology in Chinese lung adenocarcinoma patients.

Authors:  Xilin Zhang; Yan Jiang; Huanming Yu; Hui Xia; Xiang Wang
Journal:  World J Surg Oncol       Date:  2020-07-16       Impact factor: 2.754

8.  Adenocarcinoma of High-Grade Patterns Associated with Distinct Outcome of First-Line Chemotherapy or EGFR-TKIs in Patients of Relapsed Lung Cancer.

Authors:  Xiaofei Yu; Zhengwei Dong; Wanying Wang; Shiqi Mao; Yingying Pan; Yiwei Liu; Shuo Yang; Bin Chen; Chunyan Wang; Xuefei Li; Chao Zhao; Keyi Jia; Chuchu Shao; Chunyan Wu; Shengxiang Ren; Caicun Zhou
Journal:  Cancer Manag Res       Date:  2021-05-17       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.